Actinium Pharmaceuticals
ATNM
#10611
Rank
NZ$42.43 M
Marketcap
NZ$1.35
Share price
1.32%
Change (1 day)
-48.37%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -NZ$43.47 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.09 Million. In 2025 the company made an earning of -NZ$61.49 Million, an increase over its 2024 earnings that were of -NZ$71.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$43.47 Million-29.31%
2025 -NZ$61.49 Million-13.95%
2024 -NZ$71.45 Million-18.87%
2023 -NZ$88.08 Million52.24%
2022 -NZ$57.86 Million36.61%
2021 -NZ$42.35 Million11.48%
2020 -NZ$37.99 Million1.46%
2019 -NZ$37.44 Million-7.37%
2018 -NZ$40.42 Million-11.46%
2017 -NZ$45.65 Million10.67%
2016 -NZ$41.25 Million15.7%
2015 -NZ$35.66 Million-14.86%
2014 -NZ$41.88 Million129.19%
2013 -NZ$18.28 Million-8.55%
2012 -NZ$19.98 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$63.09 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA